Paris Margaritis

798 total citations
36 papers, 599 citations indexed

About

Paris Margaritis is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Paris Margaritis has authored 36 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 17 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Paris Margaritis's work include Hemophilia Treatment and Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers) and Virus-based gene therapy research (12 papers). Paris Margaritis is often cited by papers focused on Hemophilia Treatment and Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers) and Virus-based gene therapy research (12 papers). Paris Margaritis collaborates with scholars based in United States, Denmark and Sweden. Paris Margaritis's co-authors include Katherine A. High, Valder R. Arruda, Rodney M. Camire, Alexander Schlachterman, Giulia Pavani, Roland W. Herzog, Armida Faella, Élise Roy, Elizabeth P. Merricks and Lacramioara Ivanciu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Paris Margaritis

36 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paris Margaritis United States 14 313 270 198 80 64 36 599
Thomas B. Okarma United States 12 101 0.3× 234 0.9× 187 0.9× 91 1.1× 49 0.8× 21 527
Paul H. Miller Canada 15 232 0.7× 248 0.9× 67 0.3× 77 1.0× 66 1.0× 25 501
Charlotte Jubert France 11 95 0.3× 103 0.4× 106 0.5× 52 0.7× 29 0.5× 32 347
Rolf‐Dieter Wegner Germany 16 52 0.2× 270 1.0× 226 1.1× 39 0.5× 31 0.5× 38 626
Thomas H. Chase United States 7 88 0.3× 109 0.4× 94 0.5× 131 1.6× 22 0.3× 7 451
Harish P. Dave United States 11 57 0.2× 211 0.8× 94 0.5× 54 0.7× 51 0.8× 21 439
C Fahlman Norway 9 64 0.2× 295 1.1× 225 1.1× 88 1.1× 23 0.4× 12 413
Jingmei Hsu United States 14 200 0.6× 325 1.2× 52 0.3× 262 3.3× 118 1.8× 50 696
Yebo Wang China 11 70 0.2× 490 1.8× 93 0.5× 37 0.5× 24 0.4× 19 649
Mitsutaka Shiota Japan 12 106 0.3× 235 0.9× 51 0.3× 32 0.4× 131 2.0× 24 483

Countries citing papers authored by Paris Margaritis

Since Specialization
Citations

This map shows the geographic impact of Paris Margaritis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paris Margaritis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paris Margaritis more than expected).

Fields of papers citing papers by Paris Margaritis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paris Margaritis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paris Margaritis. The network helps show where Paris Margaritis may publish in the future.

Co-authorship network of co-authors of Paris Margaritis

This figure shows the co-authorship network connecting the top 25 collaborators of Paris Margaritis. A scholar is included among the top collaborators of Paris Margaritis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paris Margaritis. Paris Margaritis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Small, Juliana C., et al.. (2020). FVIII activity following FVIII protein infusion or FVIII gene transfer predicts the bleeding risk in hemophilia A rats. Journal of Thrombosis and Haemostasis. 18(7). 1586–1597. 2 indexed citations
2.
Ewing, Laura, Juliana C. Small, William E. Fantegrossi, et al.. (2020). The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse. Journal of Pharmacology and Experimental Therapeutics. 374(1). 16–23. 7 indexed citations
3.
Kristensen, Annemarie T., Paris Margaritis, Mads Kjelgaard‐Hansen, et al.. (2019). Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene‐based FVIIa prophylaxis. Haemophilia. 26(1). 164–172. 2 indexed citations
4.
Small, Juliana C., Giulia Pavani, Oscar A. Marcos‐Contreras, et al.. (2019). Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats. Blood Advances. 3(3). 301–311. 4 indexed citations
5.
González, G., et al.. (2018). Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse. PLoS ONE. 13(6). e0200060–e0200060. 4 indexed citations
6.
Pavani, Giulia, et al.. (2016). One amino acid in mouse activated factor VII defines its endothelial protein C receptor (EPCR) binding and modulates its EPCR‐dependent hemostatic activity in vivo. Journal of Thrombosis and Haemostasis. 15(3). 507–512. 4 indexed citations
7.
Pavani, Giulia, Lacramioara Ivanciu, Armida Faella, Oscar A. Marcos‐Contreras, & Paris Margaritis. (2014). The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo. Blood. 124(7). 1157–1165. 18 indexed citations
8.
Yazicioglu, Mustafa N., Kirk Chu, Fayaz R. Khazi, et al.. (2013). Cellular Localization and Characterization of Cytosolic Binding Partners for Gla Domain-containing Proteins PRRG4 and PRRG2. Journal of Biological Chemistry. 288(36). 25908–25914. 13 indexed citations
9.
Ivanciu, Lacramioara, Raffaella Toso, Paris Margaritis, et al.. (2011). A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nature Biotechnology. 29(11). 1028–1033. 62 indexed citations
10.
Nichols, Timothy C., Hongtu Zhu, Melissa C. Caughey, et al.. (2011). ARFI Ultrasound Monitoring of Hemorrhage and Hemostasis In Vivo in Canine Von Willebrand Disease and Hemophilia. Ultrasound in Medicine & Biology. 37(12). 2126–2132. 9 indexed citations
11.
DiMichele, Donna, et al.. (2011). Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency. Blood Coagulation & Fibrinolysis. 22(7). 1–1. 6 indexed citations
12.
Raymer, Robin A., Elizabeth P. Merricks, Paris Margaritis, et al.. (2010). Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B. Haemophilia. 16(s3). 19–23. 20 indexed citations
13.
Margaritis, Paris & Katherine A. High. (2010). Gene therapy in haemophilia – going for cure?. Haemophilia. 16(s3). 24–28. 7 indexed citations
14.
Margaritis, Paris, Alexander Schlachterman, Shing Jen Tai, et al.. (2008). Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. Journal of Clinical Investigation. 118(5). 1825–1834. 33 indexed citations
15.
Tai, Shing Jen, Roland W. Herzog, Paris Margaritis, et al.. (2008). A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X. Journal of Thrombosis and Haemostasis. 6(2). 339–345. 6 indexed citations
16.
Callan, Mary Beth, Paris Margaritis, Monika E. Griot‐Wenk, et al.. (2006). A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. Journal of Thrombosis and Haemostasis. 4(12). 2616–2622. 39 indexed citations
17.
Margaritis, Paris & Katherine A. High. (2006). Advances in Gene Therapy Using Factor VIIa in Hemophilia. Seminars in Hematology. 43(1 Suppl 1). S101–S104. 3 indexed citations
18.
Margaritis, Paris, et al.. (2004). Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. Journal of Clinical Investigation. 113(7). 1025–1031. 3 indexed citations
19.
Margaritis, Paris, et al.. (2004). Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. Journal of Clinical Investigation. 113(7). 1025–1031. 55 indexed citations
20.
White, Stephen J., et al.. (1998). Long-Term Expression of Human Clotting Factor IX from Retrovirally Transduced Primary Human Keratinocytes In Vivo. Human Gene Therapy. 9(8). 1187–1195. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas B. Okarma Breakdown of academic impact, for papers by Paul H. Miller Breakdown of academic impact, for papers by Charlotte Jubert Breakdown of academic impact, for papers by Rolf‐Dieter Wegner Breakdown of academic impact, for papers by Thomas H. Chase Breakdown of academic impact, for papers by Harish P. Dave Breakdown of academic impact, for papers by C Fahlman Breakdown of academic impact, for papers by Jingmei Hsu Breakdown of academic impact, for papers by Yebo Wang Breakdown of academic impact, for papers by Mitsutaka Shiota
Rankless by CCL
2026